Reviva Pharmaceuticals Holdings, Inc.
RVPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $27 | $19 | $46 | $60 |
| - Cash | $13 | $10 | $5 | $13 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $14 | $9 | $41 | $47 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$6 | -$6 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$6 | -$6 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.055 | -0.12 | -0.13 | -0.16 |
| % Growth | 54% | 7.7% | 18.8% | – |
| Operating Cash Flow | -$6 | -$5 | -$8 | -$9 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$6 | -$5 | -$8 | -$9 |